Research graph
References from From blood to bowel: correlating serological markers with mucosal healing and inflammation in patients with inflammatory bowel disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Faecal calprotectin in assessment of mucosal healing in adults with inflammatory bowel disease: a meta-analysis
10.3390/jcm10102203 · 2021 · External reference
Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease
10.18549/pharmpract.2023.1.2755 · 2023 · External reference
Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults
10.3390/diagnostics10060367 · 2020 · External reference
Fecal calprotectin and endoscopic scores: the cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease
10.3748/wjg.v30.i24.3022 · 2024 · External reference
Optimization of the most widely used serological tests for a harmonized diagnosis of Toxoplasma gondii infection in domestic pigs
10.1016/j.vetpar.2023.110024 · 2023 · External reference
A novel serum biomarker of endoscopic mucosal healing in inflammatory bowel disease
10.5217/ir.2023.00198 · 2024 · External reference
The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease
10.1016/j.advms.2018.08.001 · 2019 · External reference
The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the diagnosis and severity of inflammatory bowel disease in children
10.1007/s00431-023-05110-0 · 2023 · External reference
Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
10.1097/meg.0000000000001731 · 2020 · External reference
Surrogate markers of mucosal healing in inflammatory bowel disease: a systematic review
10.3748/wjg.v27.i16.1828 · 2021 · External reference
The role of serological markers in the prediction of disease course and response to therapy in inflammatory bowel disease
10.7759/cureus.48442 · 2023 · External reference
Diagnosis and monitoring of ulcerative colitis
10.1055/s-0042-1758047 · 2022 · External reference
Crohn's disease features in anastomotic biopsies from patients with and without Crohn's disease: diagnostic and prognostic value
10.1016/j.modpat.2023.100325 · 2023 · External reference
Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis
10.1080/00365521.2021.1991467 · 2022 · External reference
Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: a single-center observational study
10.1097/md.0000000000024717 · 2021 · External reference
Histopathological assessment of the microscopic activity in inflammatory bowel diseases: what are we looking for
10.3748/wjg.v28.i36.5300 · 2022 · External reference
Inflammatory bowel disease biomarkers
10.1002/med.21893 · 2022 · External reference
Mucosal healing and inflammatory bowel disease: therapeutic implications and new targets
10.3748/wjg.v29.i7.1157 · 2023 · External reference
Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further
10.1080/17474124.2020.1804361 · 2020 · External reference
Mucosal healing in Crohn's disease: new insights
10.1080/17474124.2020.1759416 · 2020 · External reference
Evaluation of albumin, transferrin and transthyretin in inflammatory bowel disease patients as disease activity and nutritional status biomarkers
10.3390/nu15153479 · 2023 · External reference
Serum γ-globulin and albumin concentrations predict secondary loss of response to anti-TNFα in inflammatory bowel disease patients
10.1097/meg.0000000000001493 · 2019 · External reference
Platelet/albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity
10.21203/rs.3.rs-2950900/v1 · 2023 · External reference
Serum albumin to globulin ratio is associated with the presence and severity of inflammatory bowel disease
10.2147/jir.s347161 · 2022 · External reference
Comparative evaluation of peripheral blood neutrophil to lymphocyte ratio, serum albumin to globulin ratio and serum C-reactive protein to albumin ratio in dogs with inflammatory protein-losing enteropathy and healthy dogs
10.3390/ani13030484 · 2023 · External reference
Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis
10.1136/bmjgast-2021-000662 · 2021 · External reference
Patchouli alcohol: a natural sesquiterpene against both inflammation and intestinal barrier damage of ulcerative colitis
10.1007/s10753-020-01219-8 · 2020 · External reference
The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease
10.1155/2020/3467419 · 2020 · External reference
C-reactive protein/albumin ratio and IL-6 are associated with disease activity in patients with ulcerative colitis
10.1002/jcla.24843 · 2023 · External reference
Positioning and usefulness of biomarkers in inflammatory bowel disease
10.1159/000527846 · 2023 · External reference
NLR and PLR as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF
10.1093/ibd/izaa153 · 2020 · External reference
Neutrophil-to-lymphocyte ratio (NLR) in canine inflammatory bowel disease (IBD)
10.3390/vetsci7030141 · 2020 · External reference
Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis
10.1515/jomb-2017-0050 · 2018 · External reference
Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis
10.15403/jgld.2014.1121.273.pti · 2018 · External reference
Low fecal calprotectin predicts histological healing in patients with ulcerative colitis with endoscopic remission and leads to prolonged clinical remission
10.1093/ibd/izac095 · 2023 · External reference
